SCHEMBL4128912

SCHEMBL4128912

CCCc1nn(C)c2c(=O)[nH]c(N(Cc3cccc(N4CCOCC4)c3)CC3CCCC3)nc12

nearest known ligand 0.41

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 18/20 0.41
HDAC1 Q13547 6/20 0.41
HDAC6 Q9UBN7 6/20 0.41
PDE3B Q13370 1/20 0.41
PDE3A Q14432 1/20 0.41
HDAC2 Q92769 2/20 0.40
PDE6C P51160 1/20 0.40
TERT O14746 1/20 0.38
MEN1 O00255 1/20 0.37
ALDH1A1 P00352 1/20 0.37
HPGD P15428 1/20 0.37
PDE1A P54750 1/20 0.37
PDE1B Q01064 1/20 0.37
KMT2A Q03164 1/20 0.37
PDE1C Q14123 1/20 0.37
MTOR P42345 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4123059 0.91 PDE5A (0.34) PDE5AHDAC1HDAC6PDE3BPDE3A
SCHEMBL4136646 0.89 PDE5A (0.43) PDE5AHDAC1HDAC6PDE3BPDE3A
SCHEMBL8039488 0.87 PDE5A (0.39) PDE5AHDAC1HDAC6PDE3BPDE3A
SCHEMBL8037857 0.87 PDE5A (0.42) PDE5AHDAC1HDAC6PDE3BPDE3A
SCHEMBL4901484 0.87 PDE5A (0.42) PDE5AHDAC1HDAC6PDE3BPDE3A
SCHEMBL4128842 0.87 KDM4E (0.35) ALDH1A1
SCHEMBL4892978 0.86 PDE5A (0.45) PDE5AHDAC1HDAC6PDE3BPDE3A
SCHEMBL4901618 0.86 PDE5A (0.41) PDE5AHDAC1HDAC6PDE3BPDE3A
SCHEMBL4905752 0.86 PDE5A (0.41) PDE5AHDAC1HDAC6PDE3BPDE3A
SCHEMBL8032543 0.85 HSP90AA1 (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009071706-A1 PYRAZOLEPYRIMIDINE COMPOUNDS USEFUL FOR THE TREATMENT OF DEGENERATIVE & INFLAMMATORY DISEASES GALAPAGOS NV (BE) 2009-06-11 WO disclosed
WO-2009071706-A1 PYRAZOLEPYRIMIDINE COMPOUNDS USEFUL FOR THE TREATMENT OF DEGENERATIVE & INFLAMMATORY DISEASES GALAPAGOS NV (BE) 2009-06-11 WO disclosed